Sequential manifestation of autoimmune diseases: An unusual case

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 7, 2006, Pages 777-780

  Mattiuzzo, Martina ^a   Botsios, Constantin ^a   Biscaro, Renzo ^a  

^a Ospedale Civile di Montebelluna   (Italy)

Author keywords

Overlap syndrome autoimmune hepatitis primary sclerosing cholangitis; Systemic lupus erythematosus; Ulcerative colitis

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BLOODY DIARRHEA; CASE REPORT; COLON BIOPSY; COLON ULCER; COLONOSCOPY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LAPAROSCOPIC SURGERY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ADULT; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; HEPATITIS, AUTOIMMUNE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SYNDROME;

EID: 33745236702     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000214624.45308.81     Document Type: Article

References (14)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2001; 347:417-429.
2. Stevens HP, Ostlere LS, Rustin MH. Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases. Br J Dermatol 1994; 130:385-389.
3. MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 1996; 31:907-916.
4. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Gripphits AM, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66:1863-1870.
5. Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR. State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis 2005; 11 (suppl 1):S3-S12.
6. Kovvali G, Das KM. Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Lett 2005; 579:2261-2266.
7. Pisetsky DS. Anti-DNA antibodies in SLE. Rheum Dis Clin North Am 1992; 18:437-454.
8. Golbus J, Mc Cune WJ. Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment. Rheum Dis Clin North Am 1994; 20:213-242.
9. International Autoimmune Hepatitis Group. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.
10. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004; 63:123-129.
11. Abdo AA, Bain VG, Kichian K, Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome. Hepatology 2002; 36:1393-1399.
12. Wurbs D, Klein R, Terracciano L-M, Berg PA, Bianchi L. A 28-year-old woman with a combined hepatitic/cholestatic syndrome. Hepatology 1995; 22:1598-1605.
13. Angulo P, Peter JB, Gerschwin ME, et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000; 32:182-187.
14. Cullen S, Chapman R. Primary sclerosing cholangitis. Autoimmun Rev 2003; 2:305-312.